Real estate brokerage and services firm Marcus & Millichap (NYSE:MMI) reported Q3 CY2024 results exceeding the market’s revenue expectations , with sales up 4% year on year to $168.5 million. Its GAAP loss of $0.14 per share was also 26.3% above analysts’ consensus estimates.
Is now the time to buy Marcus & Millichap? Find out in our full research report.
Founded in 1971, Marcus & Millichap (NYSE:MMI) specializes in commercial real estate investment sales, financing, research, and advisory services.
Technology has been a double-edged sword in real estate services. On the one hand, internet listings are effective at disseminating information far and wide, casting a wide net for buyers and sellers to increase the chances of transactions. On the other hand, digitization in the real estate market could potentially disintermediate key players like agents who use information asymmetries to their advantage.
A company’s long-term performance can give signals about its business quality. Even a bad business can shine for one or two quarters, but a top-tier one grows for years. Marcus & Millichap’s demand was weak over the last five years as its sales fell by 4.9% annually, a rough starting point for our analysis.
We at StockStory place the most emphasis on long-term growth, but within consumer discretionary, a stretched historical view may miss a company riding a successful new product or emerging trend. Marcus & Millichap’s recent history shows its demand has stayed suppressed as its revenue has declined by 36.3% annually over the last two years.
This quarter, Marcus & Millichap reported modest year-on-year revenue growth of 4% but beat Wall Street’s estimates by 4.7%.
Looking ahead, sell-side analysts expect revenue to grow 21% over the next 12 months, an improvement versus the last two years. This projection is healthy and indicates the market thinks its newer products and services will fuel higher growth rates.
When a company has more cash than it knows what to do with, buying back its own shares can make a lot of sense–as long as the price is right. Luckily, we’ve found one, a low-priced stock that is gushing free cash flow AND buying back shares. Click here to claim your Special Free Report on a fallen angel growth story that is already recovering from a setback.
Free cash flow isn't a prominently featured metric in company financials and earnings releases, but we think it's telling because it accounts for all operating and capital expenses, making it tough to manipulate. Cash is king.
Over the last two years, Marcus & Millichap’s demanding reinvestments to stay relevant have drained its resources. Its free cash flow margin averaged negative 9.5%, meaning it lit $9.53 of cash on fire for every $100 in revenue.
We were impressed by how significantly Marcus & Millichap blew past analysts’ revenue, EBITDA, and EPS expectations in this solid quarter. The stock remained flat at $40.18 immediately after reporting.
Is Marcus & Millichap an attractive investment opportunity at the current price? The latest quarter does matter, but not nearly as much as longer-term fundamentals and valuation, when deciding if the stock is a buy. We cover that in our actionable full research report which you can read here, it’s free.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。